Medplus Health Services announced Q2FY23 results: Q2FY23: Consolidated revenue has gone up by 21.2% over the previous year Highest-ever store expansion of 362 new stores launched in Q2FY23 Our increasing share of private label sales, 13.9% in QFY23 Our stores older than 12 months have delivered strong Store Level EBITDA margins of 9.7% and Corporate Level EBITDA margins of 4.6%, thereby maintaining the trajectory of store maturity. Result PDF
Conference Call with Medplus Health Services Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
Medplus Health Services announced Q4FY22 results: Q4FY22: 271 store net additions Revenue of Rs 966 Crore, YoY growth of 19.9% Share of Private Label 13.0% Pharmacy Operating EBITDA of Rs 39.5 Crore FY22: 667 store net additions in full year FY22 Revenue of Rs 3779 Crore, YoY growth of 23.1% (FY22 over FY21) Share of Private Label 12.7% in full year FY22 Pharmacy operating EBITDA of Rs 186 Crore in full year FY22 “In Q4FY22 we opened 288 new stores. This is a new record for MedPlus and is proof of our operational and supply chain capabilities. We will continue our growth plans in the coming quarters. Our stores greater than 12 months have delivered a store level EBITDA margin of 10.3%, thereby maintaining the trajectory of store maturity. In March we launched our first full-service Diagnostic Center and have received strong adoption from our existing and new customers.” - Gangadi Madhukar Reddy, MD & CEO, MedPlus Health Services Result PDF
Conference Call with Medplus Health Services Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.